Alembic Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALEMBIC, and what generic and branded alternatives to ALEMBIC drugs are available?
ALEMBIC has one hundred and seventy-one approved drugs.
There are ten tentative approvals on ALEMBIC drugs.
Summary for Alembic
US Patents: | 0 |
Tradenames: | 133 |
Ingredients: | 132 |
NDAs: | 171 |
Patent Litigation for Alembic: | See patent lawsuits for Alembic |
PTAB Cases with Alembic as petitioner: | See PTAB cases with Alembic as petitioner |
Drugs and US Patents for Alembic
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | SILODOSIN | silodosin | CAPSULE;ORAL | 211731-001 | Nov 22, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alembic | BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 215225-001 | Mar 29, 2023 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alembic | METRONIDAZOLE | metronidazole | TABLET;ORAL | 208681-002 | Jun 20, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.